Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: a novel HDAC inhibitor for cancer therapy. - Doreswamy CM; Seekallu S; Venkataramaiah SB; Umesh MC; Devi CS (Journal of cancer research and clinical oncology, 2025)